May 24 | Bio-IT World Brief | WuXi AppTec and Huawei launched the China Precision Medicine Cloud today. The two companies hope the platform will support the Chinese government’s Precision Medicine Initiative, and link researchers across China through a secure nationwide network.
May 23 | NPR.org | A refrigerator-sized machine could someday make lifesaving drugs on site when outbreaks occur or where medicine is in short supply, like on the battlefield.
May 19 | New York Times | Dr. Siddhartha Mukherjee offers a soaring epic, while Dr. Steven Lipkin watches a revolution in genomics unfold in the clinic.
May 19 | MIT Technology Review | By reinventing the neural network, the company hopes to help computers make the leap from processing words and symbols to comprehending the real world.
May 18 | Bio-IT World On day one of Bio-IT World Conference & Expo this year, Bio-IT World asked Michael Dimitruk, Sales Director at Accunet Solutions (one of the conference's perennial exhibitors), what he thought would be the biggest takeaway from this year's conference. His answer was seven words long: "Secure data is better than cheap data."
May 17 | Bio-IT World Brief | Dell and SAP announced a collaboration this morning to help customers optimize SAP solution environments running on clouds; deploy IoT enabled solutions; build on specialized healthcare applications; and streamline data migration and analytics with Dell’s world-class services.
May 16 | Bio-IT World News Brief | Editas Medicine today announced a three-year, $5 million agreement with Cystic Fibrosis Foundation Therapeutics this morning, and Caribou Biosciences completed a $30 million Series B financing round.
May 13 | STAT | More than 130 scientists, officials, and others met to discuss the topic of creating a large synthetic genome - including, but not limited to, humans.
May 13 | Health IT Central | Dmitry Etin, of EMC's Strategic Pursuits Team, breaks down his trends and observations from the 2016 Bio-IT World Conference & Expo.
May 12 | Bio-IT World Brief | Edico Genome and IBM have announced a collaboration to make DRAGEN available on the new IBM Power Systems S822LC for high performance computing.
May 12 | Nature News & Comment | Stem-cell scientists attempt to fend off the need for government regulation that could impede research.
May 12 | Bio-IT World Brief | The Jackson Laboratory has received a $1.2 million Science Education Partnership Award from the National Institutes of Health for Teaching the Genome Generation, The Jackson Laboratory’s teacher professional development program designed to enhance genetics instruction in high school classrooms.
May 11 | Bio-IT World | Contributed Commentary | Ketan Paranjape general manager of the Health & Life Sciences Group, Intel Corporation, welcomed the crowds at the Bio-IT World Conference & Expo last month in Boston. Paranjape’s opening address was a call to action for the Bio-IT community: harness big data and technology to achieve new heights for precision medicine.
May 11 | Nature News & Comment | Scientists must publish less, says Daniel Sarewitz, or good research will be swamped by the ever-increasing volume of poor work.
May 10 | Bio-IT World News Brief Yesterday, 10x Genomics announced the publication of a study in Nature Methods highlighting the benefits of their GemCode Technology to generate high-quality assemblies of complex genomes with their proprietary Linked-Read approach. The article demonstrates a new strategy for performing rapid, accurate and cost-effective de novo genome assembly using 10x Genomics’ Linked-Reads in combination with technologies from BioNano.
May 10 | Xconomy | The evidence is piling up. Companies with more women in charge are better businesses. So why are so many biotechs still led mainly by men?
May 10 | Computerworld | The result will be a cloud service called Watson for Cyber Security that's designed to provide insights into emerging threats as well as recommendations on how to stop them.
May 06 | Xconomy | The latest biopharmaceutical company testing Wall Street's belief in the promise of gene modification has gone public. Intellia Therapeutics sold 6 million shares at $18 each to raise $108 million.
May 06 | MIT Technology Review | A genetic therapy for "bubble boy" disease completes a 27-year journey.
May 05 | STAT | The current incentives structure - mostly based on publishing in prestigious journals - discourages sharing, replication, and, some argue, careful science.